http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-162976-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 1990-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73f85a12f07feac7e9b0e36eb8fb6f63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13531cbfd3398928fb63b4eb75ce4d62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c10255beaf5d497d3ca64c7ccb9e22b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f49956b16ac94f3b24c1edf40c0f0a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f49d833a9ba8aa98a3177ae7d42b7dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_961ecf807927ee69e357828ce929c185
publicationDate 1994-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-162976-B1
titleOfInvention Method for the production of quinazoline derivatives PL PL
abstract PROCESS FOR THE PREPARATION OF QUINAZOLINE DERIVATIVES The invention relates to a process for the preparation of quinazoline derivatives of the general Formula I (I) ¢wherein R1 and R2 may be the same or different and stand for hydrogen or lower alkyl or together form an ethylene (-CH2-CH2-) or trimethylene (-CH2-CH2- -CH2-) group; and n is the integer number 2 or 37 and pharmaceutically acceptable acid addition salts thereof, which comprises a) reacting an isothiourea derivative of the general Formula III (III) ¢wherein R stands for lower alkyl or phenyl-lower alkyl, where the phenyl ring of the latter group may be optionally substituted by one or more lower alkyl group(s) and/or halogen atom(s)! with an amine of the general Formula IV, (IV) (wherein R1, R2 and n are as stated above) at a temperature between 150 .degree.C and 280 .degree.C; or b) cyclising a compound of the general Formula II (II) (wherein R1, R2 and n are as stated above) optionally in the presence of a catalyst; and, if desired, converting a compound of the general Formula I thus obtained into a pharmaceutically acceptable acid addition salt thereof.
priorityDate 1989-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129718698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413315717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419595401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID551254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12622371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450459896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409994468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415739720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414524877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425478151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451581464

Total number of triples: 73.